February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Discovering Complex Clinical and Pathological Features

Virtual 2021 International Conference on Alzheimer’s & Parkinson’s Diseases

Exploring the Varying Clinical Presentations of Alzheimer’s Disease

Sharon Cohen, MD, FRCPC, discusses the varying clinical presentations of Alzheimer’s disease, including the changeability of neuropsychiatric, cognitive, and behavioral symptoms of typical and atypical Alzheimer’s disease phenotypes. She continues by comparing the clinical characteristics of early-onset Alzheimer’s disease with late-onset Alzheimer’s disease and analyzes clinical profiles across a range of dementia etiologies. The focus of Dr. Cohen’s presentation then turns to how clinical assessment tools can be used to identify such dementia etiologies, with reference to the patient case study. The panelists then explore how the COVID19 pandemic has affected the assessment of patients with suspected cognitive, functional, or behavioral impairments.

Key Learning Objectives for Biogen’s ADPD 2021 Symposium:

  • Understand how mixed pathologies and varying clinical presentations can affect the early diagnosis of Alzheimer’s disease
  • Gain insights into how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an early diagnosis of Alzheimer’s disease in challenging cases with mixed pathologies
  • Assess the current healthcare system readiness for timely diagnosis of Alzheimer’s disease and management of patients

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.